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Summary
Objective: To investigate the effect of L-glutamine (Gln) on stress responses of chondrocytes exposed to heat stress or nitric oxide (NO).
Methods: Cultures of articular chondrocytes were established from rabbit joints, and treated for 12 h with various concentrations of Gln
(0e20 mM). In some experiments, cells were also treated with quercetin (Que), a heat shock protein 70 (HSP70) inhibitor. Heat stress
(43(C) was applied to the cells for 0e120 min. Apoptosis was induced by 0.5 mM sodium nitroprusside (SNP) dihydrate that produces
NO. After stress loading, HSP70 expression was detected by Western blot analysis. Cell viability was assessed by lactate dehydrogenase
(LDH) release and tetrazolium salt-based assays, while apoptosis was evaluated by Hoechst 33342 staining, TUNEL methods and active cas-
pase-3 determination.
Results: Gln demonstrated dose-dependent enhancing effect on stress-mediated induction of HSP70, while in the absence of any stress
HSP70 was not induced by Gln alone. After heating or SNP loading, chondrocytes showed severe reduction in viability, while the cytotoxic
outcome was almost completely abrogated by conditioning with Gln. The protective effect of Gln was signiﬁcantly blocked by Que that effec-
tively suppressed stress-induced HSP70 expression in chondrocytes. The Gln also rendered chondrocytes unsusceptible to NO-induced ap-
optosis that was frequently seen in SNP-treated culture.
Conclusion: This study demonstrated that the treatment of chondrocytes with Gln protected the cells from heat stress and NO-induced apo-
ptosis. These chondroprotective effects of Gln may be mediated by HSP70.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a progressive disorder associated
with degeneration and destruction of articular cartilage.
The serious impairment of joint function results in disability
of daily and social activities of patients. Currently prescribed
conservative therapies include oral administration of non-
steroidal anti-inﬂammatory drugs and intra-articular injec-
tion of hyaluronan. Although these therapies are partially
effective in controlling the disease and alleviating pain,
they fail to sufﬁciently suppress the progression of cartilage
degeneration. In case severe cartilage destruction devel-
oped at the terminal stage of OA, surgical procedure includ-
ing total endoprosthetic replacement is selected for the
treatment. Although clinical results reveal its usefulness,
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gree of invasiveness such as bleeding and thromboembo-
lism, poor long-term prognosis1,2 and high economical
burdens. Thus, it is necessary to develop an efﬁcient, sim-
ple and inexpensive therapeutic modality that prevents car-
tilage degeneration at initial stages of OA.
Recently, there are increasing reports of drugs or biolog-
ical products that can effectively retard or stop the progres-
sion of OA. In particular, a great attention is focused on
glucosamine and chondroitin sulfate, which are sometimes
classiﬁed into the disease-modifying OA drugs (DMOADs).
Some reports have shown that these substances beneﬁt
chondrocytes by inhibiting cartilage catabolic factors and
improving their biosynthetic activity in vitro3e6. Their clinical
efﬁcacies are being assessed by several methods7, and it
was shown that an administration of these agents at least
partially prevents the joint structure changes and improves
symptoms in patients with OA8,9. They are relatively inex-
pensive, potentially generating favorable patient compli-
ance. However, it is commonly assumed that neither
glucosamine nor chondroitin sulfate is satisfactorily effec-
tive per se in preventing the progression of OA.
L-Glutamine (Gln) is one of the most abundant free amino
acids in the body, playing important roles in regulating45
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sized as a nonessential amino acid and pooled mainly in
plasma and skeletal muscle. However, under extremely
stressful situations including injury, surgery and infection
in particular, the Gln is consumed as an important energy
source, and the Gln concentrations in blood and tissue
are reduced10e12. Under such conditions, an administration
of exogenous Gln has been shown to be beneﬁcial for var-
ious organs. More speciﬁcally, it protects gastrointestinal
epithelial cells from various stresses in vitro13e15 and pre-
serves the gastrointestinal tract in vivo following burns16, ir-
radiation17 and surgical treatment18,19. Administration of
Gln also prevents various organs from injuries caused by
sepsis-induced endotoxin shock20 and by cardiopulmonary
bypass-induced inﬂammatory response21. Other studies
in vitro indicated that Gln protects alveolar epithelial cells
from hyperoxic stress22,23, and inhibits apoptosis of acti-
vated T cells and neutrophils24,25. Although the precise
mechanism underlying these phenomena remains to be dis-
closed, heat shock protein 70 (HSP70) may play indispens-
able roles in the protective effects of Gln14,20,21,26.
In the pathogenesis of OA, various biological and chem-
ical stress factors are believed to be involved in the onset
and progression of the disorder. These include nonphysio-
logical mechanical loading and heat stress caused by aber-
rant joint movement. It is widely believed that inﬂammatory
cytokines such as interleukin-1 (IL-1) and tumor necrosis
factor-a (TNF-a) as well as reactive oxygen species
(ROS) such as nitric oxide (NO) are induced under the
stress conditions and contribute to the pathogenesis of
OA. Although Gln was previously shown to play a regulatory
role in extracellular matrix metabolism in cartilage27, the ef-
fect of Gln on chondrocytes has not been fully elucidated.
To clarify the functions of Gln on stressed chondrocytes,
we treated chondrocytes with Gln and assessed its effects
on cell injuries triggered by high temperature or NO. We
also analyzed the expression of HSP70 to elucidate the
mechanisms of chondroprotective effect of Gln.
Materials and methods
This study was conducted according to the regulations
regarding animal research of Kyoto Prefectural University
of Medicine.
PREPARATION OF CHONDROCYTES
A total of 32 male Japanese white rabbits (9e11 weeks
old) (Shimizu Laboratory Supplies, Kyoto, Japan) were
used to assess the reproducibility of repeated experiments
in this study. In each experiment, two rabbits were eutha-
nized by administering a lethal dose of sodium pentobarbital
(Nembutal; Abbot, North Chicago, IL), and the cartilage was
aseptically collected from the bilateral joints of the knee, hip,
and shoulder. The mixed specimens were minced into small
pieces, treated with 0.015% trypsin (Gibco BRL, Gaithers-
burg, MD) for 1 h, and subsequently digested with 0.025%
collagenase (Collagenase S-1; Nitta Gelatin, Osaka, Japan)
for 8 h. The isolated chondrocytes were cultured as mono-
layers in 75 cm2 ﬂasks (BD Biosciences, Bedford, MA) for
1 week at 37(C in 5% CO2/95% humidiﬁed air (standard
conditions) in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) with 4 mM Gln (Nacalai Tesque, Kyoto, Japan)
supplemented with 10% fetal bovine serum (FBS) (Trace
Scientiﬁc Ltd., Melbourne, Australia), 100 units/ml penicillin,and 100 mg/ml streptomycin (Gibco BRL) (complete
DMEM).
Gln AND QUERCETIN (QUE) TREATMENT
Chondrocytes were treated with trypsin/ethylenediamine-
tetraacetic acid (EDTA) and resuspended in complete
DMEM and seeded in 6-well culture plates (Asahi Techno
Glass, Tokyo, Japan) or 8-well chamber slides (Asahi Techno
Glass) at a density of 5 104 cells/cm2. After 24 h of cultiva-
tion under the standard conditions, the cells were washed
and the culture medium was replaced with Gln-free DMEM
(Nissui Pharmaceutical, Tokyo, Japan) including 0, 2, 5, 10
or 20 mM of Gln (SigmaeAldrich, St. Louis, MO) supple-
mented with 10% FBS, 100 units/ml penicillin, and 100 mg/ml
streptomycin. For comparison of Gln with other amino acids,
20 mM of L-serine (Ser) (SigmaeAldrich) and L-alanine (Ala)
(SigmaeAldrich) were also used. The cells were further
cultured for 12 h under the standard conditions. In some ex-
periments, Que (SigmaeAldrich) was added to the chondro-
cyte culture at a ﬁnal concentration of 200 mM.
STRESS EXPOSURE
To apply heat stress to chondrocytes, the culture plates
were carefully sealed and placed in a circulatory hot water
bath set at 39, 41, 43, 45 and 47(C. After incubation for
0e120 min, the plates were removed from the bath and cul-
tured under the standard conditions. Control cells were kept
in water bath at 37(C for the same duration.
The sodium nitroprusside (SNP) treatment was per-
formed as described28. According to this report, the concen-
tration of SNP for apoptosis induction of chondrocyte was
set at 0.5 mM. Brieﬂy, SNP dihydrate (Wako, Osaka,
Japan) was added to the culture medium at a ﬁnal con-
centration of 0.5 mM. The cells were cultured for 10 h under
the standard conditions.
WESTERN BLOT ANALYSIS
Cells were washed twice with phosphate buffered saline
(PBS) and extracted in lysis buffer (1% NP-40, 150 mM
NaCl, 5 mM EDTA, 50 mM NaF, 20 mM TriseHCl pH
7.5, 2 mM Na3VO4, 1 mM phenylmethylsulphonylﬂuoride
(PMSF) and protease inhibitor cocktail). The cell extract
containing 5 mg of protein was separated by sodium do-
decyl sulfate (SDS)-polyacrylamide gel electrophoresis ac-
cording to the method of Laemmli29. After transferring to
polyvinylidene diﬂuoride membranes (Hybond-P; Amer-
sham Pharmacia biotech, Buckinghamshire, UK), HSP70
was detected by incubating the blot with anti-HSP70
monoclonal antibody (Bio Vision, Mountain View, CA,
USA) and alkaline phosphatase-conjugated anti-mouse
IgG antibody (Promega, Madison, WI, USA). b-Actin was
also detected by anti-b-actin monoclonal antibody (Sigmae
Aldrich). The chemiluminescent emission was identi-
ﬁed with substrate solution containing 1.73 mM of nitroblue
tetrazolium (NBT) and 1.15 mM of 5-bromo-4-chloro-3-
indolyl phosphate (BCIP). Caspase-3 was detected by
anti-caspase-3 polyclonal antibody (CalbiochemeNovabio-
chem, San Diego, CA) that recognized the 34-kDa procas-
pase-3 and the 20- and 18-kDa active caspase-3 and
HRP-conjugated anti-rabbit IgG antibody (Amersham,
Arlington Heights, IL). The chemiluminescent emission
was identiﬁed using an ECL plus Western blotting detec-
tion kit (Amersham).
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Lactate dehydrogenase (LDH) release assay was per-
formed as described28. Brieﬂy, 100 ml of culture medium
was harvested and mixed with 100 ml of the reaction solu-
tion containing 2.6 mM nicotinamide adenine dinucleotide,
0.49 mM NBT, and 1.8 units/ml diapharose (LDH CII kit;
Wako). After incubation under the standard conditions for
10 min, the reaction was terminated by adding 50 ml of
0.5 N HCl, and the optical densities (ODs) at 570 and
690 nm were measured by a spectrophotometer.
For tetrazolium salt-based assay, cells were incubated
with 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium monosodium salt (WST-8,
Nacalai Tesque) for 2 h under the standard conditions.
OD at 450 nm was measured by a spectrophotometer.
MORPHOLOGICAL OBSERVATION AND APOPTOSIS
DETECTION
For DNA visualization, chondrocytes were stained with
2% Hoechst 33342 (Nacalai Tesque) in 10% FBS/DMEM
under the standard conditions for 30 min. The cells were ob-
served under a ﬂuorescence microscope.
TUNEL staining was carried out using a TUNEL kit (ﬂuo-
rescein in situ cell detection kit; Roche Diagnostics, Man-
nheim, Germany) as described28. Cells were analyzed
under a ﬂuorescence microscope.
STATISTICAL ANALYSES
Statistical signiﬁcances between Gln-treated and -free
groups or Que-treated and -free groups are analyzed by
Student’s t-test. P values less than 0.05 were regarded sta-
tistically signiﬁcant.
Results
In all duplicated or triplicated experiments for each test
item, almost identical results were obtained. Figures are
the representative case of the repeated experiments.
Gln AUGMENTED HSP70 EXPRESSION IN STRESSED
CHONDROCYTES
To examine whether Gln affects HSP70 induction, cul-
tures of chondrocytes were incubated with various concen-
trations of Gln, and after heating at 43(C for 120 min
HSP70 expression was assessed by Western blot analysis.
The expression levels of HSP70 were dose-dependently
augmented by Gln (Fig. 1, middle panel). In the absence
of the stress, however, HSP70 was not detected regardless
of the Gln concentrations (Fig. 1, upper panel). Similar re-
sults were also obtained by other experiments in which
cell stress was loaded to chondrocytes by an addition of
SNP instead of heat. After SNP loading, HSP70 was detect-
able in the groups treated with Gln at 5, 10 or 20 mM (Fig. 1,
lower panel). These ﬁndings indicate that Gln enhances
stress-induced HSP70 expression in chondrocytes.
Gln AMELIORATED CHONDROCYTE DAMAGE CAUSED
BY HIGH TEMPERATURE
Our preliminary experiments showed that signiﬁcant cyto-
toxicity was not detected when chondrocytes were heated at
39 and 41(C, while thermal treatment at 43, 45 and 47(Ccaused signiﬁcant decrease of cell viability (data not shown).
In addition, 45 and 47(C heat stresses exerted strong lethal
effects that could not be rescued by Gln (data not shown).
Therefore, the heat stress in the present study was set at
43(C.
To examine the effect of Gln on heat stress-induced
death of chondrocytes, LDH release assay was performed
to evaluate viability of cells that had been conditioned with
various concentrations of Gln and heated at 43(C for
120 min. Twenty-four hours after the hyperthermic treat-
ment, the Gln-untreated cells released a signiﬁcant amount
of LDH, while the LDH release was drastically inhibited in
the Gln-treated groups [Fig. 2(A)]. The ﬁndings were also
conﬁrmed by tetrazolium salt-based assay, which revealed
that the cell viabilities in the Gln-treated groups were posi-
tively correlated with the Gln concentrations 24 h after heat-
ing [Fig. 2(B)]. Supplementation with 20 mM of Gln
successfully canceled the cell death that was otherwise in-
duced by heat stress at 43(C for 60, 90 or 120 min
[Fig. 2(C)]. These chondroprotective effects of Gln were
also remarkable when compared with other nonessential
amino acids such as Ser and Ala [Fig. 2(D)].
QUE INHIBITED HSP70 INDUCTION AND DIMINISHED
CYTOPROTECTION OF Gln
Que is a major ﬂavonoid in the plant kingdom, and one of
its functions is to inhibit the synthesis of HSP7030,31. We as-
sessed whether Que inﬂuenced the insusceptibility of Gln-
treated chondrocytes to stress-induced cell damage. First,
Western blot analysis was performed to conﬁrm that Que in-
hibits expression of HSP70 in chondrocytes. It was shown
that 200 mM Que effectively down-regulated HSP70 that
was elicited by Gln and heat stress [Fig. 3(A)].
The tetrazolium salt-based assay was then carried out to
evaluate the viability of cells that had been treated with Gln
and/or Que followed by loading with heat stress. It was indi-
cated that Que completely abolished the chondroprotective
Concentration of Gln (mM)
0 2 5 10 20
No
Stress - 70 kDa
Heat
Stress - 70 kDa
- 70 kDaSNP
HSP70 by Western Blot
Fig. 1. Stress-induced expression of HSP70 was enhanced in
chondrocytes by supplementation of Gln. Cultures of articular chon-
drocytes were treated with 0, 2, 5, 10 or 20 mM of Gln for 12 h. The
cells were then incubated at 43(C for 120 min (middle panel), cul-
tured with 0.5 mM SNP dihydrate (lower panel) or not subjected to
any stress (upper panel). Four (middle panel) or 10 (lower panel)
hours later cells were extracted and the lysates were subjected to
the Western blot analysis using the anti-HSP70 antibody as
a probe.
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Fig. 2. Protective effect of Gln against cellular injury caused by heat stress. (A and B) Chondrocytes were treated with 0, 5, 10 or 20 mM of Gln
for 12 h, followed by incubation at 43(C for 120 min. Control cells were neither treated with Gln nor incubated at high temperature. Twenty-four
hours after the heating, LDH release (A) and tetrazolium salt-based (B) assays were performed. MeansSD of ODs are shown (n¼ 6 for
each group). Statistical signiﬁcances between Gln-treated and -free groups after heat stress exposure are analyzed by Student’s t-test.
(C) Chondrocytes were treated with 20 mM Gln for 12 h, followed by incubation at 43(C for 0, 30, 60, 90 or 120 min. Twenty-four hours later
cells were subjected to the tetrazolium salt-based assay. Values are the meansSD of ODs (n¼ 6 for each group). Statistical signiﬁcances
between Gln-treated and -free groups at each time point are analyzed by Student’s t-test. (D) Chondrocytes were treated with 20 mM Gln, Ser
and Ala for 12 h, followed by incubation at 43(C for 120 min. Twenty-four hours later cells were subjected to the tetrazolium salt-based assay.
Values are the meansSD of ODs (n¼ 6 for each group). Statistical signiﬁcances between Gln-treated and other groups after heat stress
exposure are analyzed by Student’s t-test.effect of Gln against thermal stress [Fig. 3(B)], suggesting
that the HSP70 essentially participated in the Gln-mediated
inhibition of cytotoxicity triggered by stresses.
Gln SUPPRESSED NO-INDUCED APOPTOSIS
OF CHONDROCYTES
To examine whether Gln interferes with NO-induced cyto-
toxicity in chondrocytes, cells cultured with/without Gln were
treated with SNP and subsequently subjected to LDH
release assay. As shown in Fig. 4, Gln suppressed LDH
release from the SNP-treated cells in a dose-dependent
manner, and the LDH release was almost completely
blocked by 20 mM of Gln. These ﬁndings indicate that Gln
blocks the fatal inﬂuence of SNP on chondrocytes.Next, Hoechst 33342 staining was performed to examine
morphological changes in the chondrocytes. In the Gln-
untreated group, numerous chondrocytes exhibited typical
characteristics of apoptosis with highly fragmented, con-
densed or divided nuclei [Fig. 5(A)]. In contrast, very few ap-
optotic cells were observed in the Gln-treated culture
[Fig. 5(B)]. The results were conﬁrmed by calculating the
percentages of apoptotic cells. As shown in Fig. 6(A), the
Gln-treated group consisted of a small proportion of
Hoechst-positive cells (6.6 1.0%), while a signiﬁcantly
larger proportion of cells in the Gln-untreated group under-
went programmed cell death (26.9 3.2%).
TUNEL staining was also performed to assess DNA frag-
mentation in the chondrocytes. A number of apoptotic nuclei
with double-strand DNA breaks were observed in the Gln-
untreated group [Fig. 5(C)], while apoptotic cells were rarely
549Osteoarthritis and Cartilage Vol. 14, No. 6demonstrated in the Gln-treated populations [Fig. 5(D)].
Numerical analysis indicated that the TUNEL-positive
cells accounted for only 1.3 0.9% of the Gln-treated
chondrocytes, which was in sharp contrast with the obser-
vation that apoptotic cells were abundant among the chon-
drocytes that were not treated with Gln (17.1 3.2%)
[Fig. 6(B)].
To investigate the enzymatic involvement in NO-induced
chondrocytes’ apoptosis, Western blot analysis of caspase-3
was performed. Caspase-3 is a key molecule that medi-
ates the ﬁnal stage of cell death by apoptosis. Western
blot analysis revealed that SNP induced cleavage of pro-
caspase-3 into the active form of caspase-3 in Gln-
untreated chondrocytes, while this cleavage was blocked
in Gln-treated chondrocytes (Fig. 7). These results sug-
gested that supplementation of Gln prevented the activation
of caspase-3 in chondrocytes.
Taken together, Gln suppressed NO-induced apoptosis
of cultured chondrocytes.
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Fig. 3. Que inhibited chondroprotective effects of Gln. (A) Chondro-
cytes were cultured with the indicated concentrations of Gln in the
presence or absence of 200 mM of Que. After 12 h of culture, heat
stress (43(C for 120 min) was applied to the cells. Control cells
were neither given Gln or Que, nor heat stress. Four hours later
cells were extracted and Western blot analysis was performed to
evaluate HSP70 and b-actin expressions. (B) Chondrocytes were
treated with Gln and/or Que as above, and incubated at 43(C for
120 min. Twenty-four hours later, cell viability was evaluated by tetraz-
olium salt-based assay as in Fig. 2. Values are the means SD
of ODs (n¼ 6 for each group). Statistical signiﬁcances between
Que-treated and -free groups are analyzed by Student’s t-test.Discussion
This study clearly demonstrated for the ﬁrst time that Gln
protected chondrocytes from heat stress and NO-induced
apoptosis. These effects of Gln could be utilized to protect
chondrocytes from various forms of stress present in OA
patients, and to prevent the progression of cartilage degen-
eration. It is suggested that Gln may serve as a potential
candidate molecule for OA therapeutics.
It was reported that physiological movement of a joint
elevates the temperature in the joint cavity by 2.5(C32. In
patients with OA, the intra-articular temperature is possibly
elevated to a further higher degree due to local inﬂamma-
tion and aberrant frictional force induced by nonphysiologi-
cal mechanical loading32. Previous reports showed that
hyperthermia induced damage to articular cartilage33 and
ﬁbrillated arthritic cartilage was susceptible to thermal chal-
lenge compared with normal cartilage34. Although precise
thermal increase in OA joint is unclear, heat stress is sug-
gested to result in acceleration of the cartilage degenera-
tion. In this study, we tested the effect of heat stress on
cultured chondrocytes. First, we examined the thermal con-
dition to induce effective cytotoxicity in chondrocytes. Ac-
cording to these results, chondrocytes were signiﬁcantly
injured by 43(C heat stress as shown in other cells35e38,
and we evaluated the effect of Gln on chondrocytes ex-
posed to 43(C thermal stress in the following experiments.
Recent studies demonstrated apoptotic chondrocytes in
OA cartilage in humans and animal models, and the rela-
tionship between OA and chondrocyte apoptosis has
been clearly ﬁgured out39e41. Chondrocytes undergo apo-
ptosis under unphysiological mechanical or biological
stresses due to inﬂammatory cytokines such as IL-1, as
well as to ROS such as NO. In the rabbit OA model, NO pro-
duction by chondrocytes correlated with the frequency of
apoptotic cells40,42. Thus, it is suggested that NO-induced
apoptosis of chondrocytes is involved in the pathogenesis
of OA.
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Fig. 4. Inhibition of SNP-induced LDH release by Gln supplementa-
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12 h, and subsequently cultured with 0.5 mM SNP dihydrate. Con-
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hours later, LDH release assay was performed. Means SD of
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D) staining. Fluorescence microscopic images are shown.The cytoprotective effect of Gln could be mediated by
various mechanisms. Since Gln is a component of glutathi-
one, which is an essential intracellular antioxidant, the Gln-
induced elevation of stress responses could be mediated by
glutathione. During stress loading, exogenous Gln supple-
mentation has been shown to increase the concentration
of glutathione that protects cells from injury15,19,23,24. Alter-
natively, Gln is a precursor of glucosamine12,43, which is
a major component of proteoglycans. Glucosamine inhibits
cartilage destruction and promotes biosynthetic activity of
chondrocytes3e6. The Gln may upregulate glucosamine
synthesis in chondrocytes, which may lead to chondropro-
tective function of Gln.
Despite these possible explanations, our present study
focused on HSP70 as an essential mediator of chondropro-
tective mechanisms of Gln, showing that partial inhibition of
HSP70 by Que effectively attenuated the inﬂuence of Gln
on stress response of chondrocytes. These results sug-
gested that chondroprotective effect of Gln might be medi-
ated by HSP70. In some types of cells other thanchondrocytes, Gln was shown to enhance HSP70 expres-
sion under the stressed or unstressed conditions14,20,21,26,
although it was not reported whether this is also true of
chondrocytes. HSPs constitute a family of highly conserved
proteins which are synthesized in cells after stress loading.
HSPs not only protect cells from various forms of stress, but
also facilitate the recovery from stress-induced cell injury as
molecular chaperones44e46. In particular, HSP70 is a major
HSP and its expression levels in chondrocytes are corre-
lated with histological severity in OA47,48. However, the
mechanisms of HSP70 induction and pathophysiological
signiﬁcance of HSP70 in OA have not been fully under-
stood. In our previous studies that were conducted to inves-
tigate the roles of HSP70 in chondrocytes, we genetically
transduced HSP70 gene into chondrocytes by means of
the adenovirus vectors, demonstrating that overexpression
of HSP70 resulted in promotion of metabolic activity of
chondrocytes49, protection of chondrocytes from heat
stress50, and inhibition of NO-induced apoptosis of chon-
drocytes28. In chondrocytes of OA patients, however, the
551Osteoarthritis and Cartilage Vol. 14, No. 6expression level of HSP70 may not be high enough to elim-
inate stress-induced damage of cartilage, which may be
a cause of the progression of the disorder. Control of
HSP70 expression may provide a novel therapeutic strat-
egy for OA.
This study suggested that Gln enhanced HSP70 expres-
sion and ampliﬁed stress response in chondrocytes, al-
though only under stressed conditions. Based on these
ﬁndings, it is reasonable to postulate that administration of
Gln to OA cartilage, in which stress response via HSP70
is present, induces sufﬁcient increase of HSP70 for thera-
peutic purposes in vivo. In addition, supplementation of
Gln in combination with moderate heat treatment, which
stimulates initial stress response without cytotoxicity, may
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Fig. 6. NO-induced apoptosis of chondrocytes was suppressed by
Gln supplementation. Chondrocytes were treated with 0 or 20 mM
of Gln, followed by culturing with SNP dihydrate as in Fig. 4. Ten
hours later, cells were subjected to Hoechst 33342 (A) or TUNEL
(B) staining. MeansSD of percentages of Hoechst- or TUNEL-
positive cells are shown (n¼ 5 for each group). Statistical signiﬁ-
cances between Gln-treated and -free groups after SNP exposure
are analyzed by Student’s t-test.be also helpful to achieve further high expression level of
HSP70 in vivo. As several clinical trials for other disorders
have demonstrated51e53, administration of Gln is simple, in-
expensive and safe. Therefore, Gln may be relatively easily
applicable to clinical use for OA and becomes a suitable
therapy to be co-administered to OA patients with conven-
tional DMOADs. In addition, present ﬁndings strongly sug-
gest that Gln may also have the potential to become
a novel DMOAD.
In conclusion, supplementation of Gln could provide
a novel therapeutic approach to OA, aiming at augmenta-
tion of the protective response of chondrocytes to various
stresses. Regarding practical application of Gln, preclinical
studies should be required for determining the optimum
dosage and method for administration of Gln, employing
some animal model systems with experimental OA.
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